PERCUSENSE

PercuSense aims to
improve outcomes
and reduce the
cost of sepsis, the
primary diagnosis
in more than 1.2
million hospitalizations in the U.S.

The company’sdevice, SIRSDx, isbeing developed forthe early identifica-tion and treatmentof sepsis to preventits progression inpatients. The low-cost, minimally invasive sensor device is designed to continuously measure lactate, glucose, tissue oxygenation,tissue perfusion and temperature to enable rapid feedback for therapy optimization in a disease where time iscritical, thus improving sepsis mortality and saving patient lives. The device can be placed on at-risk patients notonly in the hospital, but also in ambulatory settings for early monitoring and diagnosis of sepsis risk.

PHOTONICARE

Ear infections occur in four out of
five children, yet
care providers have
had no choice but
to make subjective
diagnoses based
largely on the surface appearance of
the eardrum due to
outdated technology, and resulting
in misdiagnoses of
up to 50%, over-prescription of antibiotics, and unnecessary or delayed surgeries. PhotoniCare’s handheld ear imaging tool uses an advanced light-based technology
designed to see through the eardrum and into the middle ear. The non-invasive imaging technology is similar to
the ultrasound, except that it uses near-infrared light waves instead of sound waves to provide 3D views inside
living tissue to eliminate guesswork, replacing subjective diagnosis with objective data.